Dapoxetine Impurity 11 | CAS 2245197-07-1 - Request Quote
Dapoxetine Impurity 11
| SZ CAT No: | SZ-D070020 |
| CAS No | 2245197-07-1 |
| Mol.F. | C30H31NO |
| Mol.Wt. | 421.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dapoxetine Impurity 11 is chemically 3-((4-Cinnamylnaphthalen-1-yl)oxy)-N,N-dimethyl-1-phenylpropan-1-amine. Dapoxetine Impurity 11 is supplied with detailed characterization data compliant with regulatory guideline. Dapoxetine Impurity 11 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dapoxetine .
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2245197-07-1
Purchase 2245197-07-1
Order 2245197-07-1
Enquire 2245197-07-1
price of 2245197-07-1
2245197-07-1 Supplier
2245197-07-1 Manufacturer
2245197-07-1 Exporter
buy high quality Dapoxetine Impurity 11
Purchase Dapoxetine Impurity 11
Dapoxetine Impurity 11 suppliers
Dapoxetine Impurity 11 manufacturers
Dapoxetine Impurity 11 price
Order Dapoxetine Impurity 11
Enquire Dapoxetine Impurity 11
Dapoxetine Impurity 11 cost
Dapoxetine Impurity 11 Supplier
Dapoxetine Impurity 11 Distributor
Dapoxetine Impurity 11 for Method Validation
Dapoxetine Reference Standard
Dapoxetine Impurity 11 for ANDA Filing
Dapoxetine Impurity 11 for Forced Degradation Studies
Dapoxetine Impurity 11 Identification Standards
Dapoxetine Impurity 11 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.